We've just published ASHAVI's Vietnam Healthcare Market Intelligence report (May 2026) — a consolidated view of where the market stands and what it takes to win here.
Three things we learned while putting together our Vietnam healthcare report:
Access beats product. Tender listing and reimbursement decide whether a drug can be used at all.
Pharmacies are the volume engine, not hospitals. 80% of Vietnamese buy medicine directly at one of 62,000+ outlets.
The biggest opportunity is the least monetized. Cardiovascular patients number ~22 million, but annual spend is only ~$35 per patient.
ASHAVI's Vietnam Healthcare Market Intelligence, May 2026 — market sizing, competitive landscape, patient journey, physician behavior and six strategic imperatives.
Read more: https://drive.google.com/file/d/1gl9-Rw5xG_VyfyE7miDcNG5ZRKfADjtA/view?usp=sharing
